Aclaris Therapeutics, Inc.

Historical 13F Holders

Symbol
ACRS
CUSIP
00461U105
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 7 9.70 M $12.0 M
2023 Q4 113 59.0 M $61.9 M
2023 Q3 164 70.1 M $480 M
2023 Q2 152 71.1 M $737 M
2023 Q1 177 71.7 M $580 M
2022 Q4 135 67.1 M $1.06 B
2022 Q3 132 64.0 M $1.01 B
2022 Q2 118 63.3 M $883 M
2022 Q1 114 59.3 M $1.02 B
2021 Q4 140 57.0 M $828 M
2021 Q3 132 56.8 M $1.02 B
2021 Q2 140 56.9 M $998 M
2021 Q1 110 46.1 M $1.31 B
2020 Q4 93 32.1 M $207 M
2020 Q3 61 25.6 M $65.7 M
2020 Q2 64 28.7 M $46.4 M
2020 Q1 74 32.1 M $33.4 M
2019 Q4 83 31.4 M $59.3 M
2019 Q3 84 29.1 M $31.4 M
2019 Q2 92 36.0 M $78.8 M
2019 Q1 100 37.9 M $227 M
2018 Q4 100 39.4 M $291 M
2018 Q3 90 30.6 M $444 M
2018 Q2 101 32.8 M $654 M
2018 Q1 101 30.7 M $537 M
2017 Q4 104 28.5 M $703 M
2017 Q3 108 28.5 M $737 M
2017 Q2 107 25.6 M $695 M
2017 Q1 115 23.7 M $708 M
2016 Q4 102 21.4 M $581 M
2016 Q3 59 15.5 M $397 M
2016 Q2 48 15.4 M $284 M
2016 Q1 34 14.6 M $277 M
2015 Q4 35 10.3 M $279 M